These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 8246705)

  • 1. Markov models in medical decision making: a practical guide.
    Sonnenberg FA; Beck JR
    Med Decis Making; 1993; 13(4):322-38. PubMed ID: 8246705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Decision analysis in radiology using Markov models].
    Golder W
    Rofo; 2000 Jan; 172(1):80-5. PubMed ID: 10719468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Markov series and Monte Carlo simulation in predicting replacement valve performances.
    de Kruyk AR; van der Meulen JH; van Herwerden LA; Bekkers JA; Steyerberg EW; Dekker R; Habbema JD
    J Heart Valve Dis; 1998 Jan; 7(1):4-12. PubMed ID: 9502132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Markov process in medical prognosis.
    Beck JR; Pauker SG
    Med Decis Making; 1983; 3(4):419-458. PubMed ID: 6668990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid approximation of confidence intervals for Markov process decision models: applications in decision support systems.
    Cher DJ; Lenert LA
    J Am Med Inform Assoc; 1997; 4(4):301-12. PubMed ID: 9223036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of basiliximab induction in "old-to-old" kidney transplant programs: Bayesian estimation, simulation, and uncertainty analysis.
    Emparan C; Wolters H; Laukötte M; Senninger N
    Transplant Proc; 2005 Jun; 37(5):2069-71. PubMed ID: 15964341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations in uncertainty analysis for medical decision making: an application to heart-valve replacement.
    Chessa AG; Dekker R; van Vliet B; Steyerberg EW; Habbema JD
    Med Decis Making; 1999; 19(3):276-86. PubMed ID: 10424834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scalable approximate policies for Markov decision process models of hospital elective admissions.
    Zhu G; Lizotte D; Hoey J
    Artif Intell Med; 2014 May; 61(1):21-34. PubMed ID: 24791675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probabilistic analysis of decision trees using Monte Carlo simulation.
    Critchfield GC; Willard KE
    Med Decis Making; 1986; 6(2):85-92. PubMed ID: 3702625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choosing the order of deceased donor and living donor kidney transplantation in pediatric recipients: a Markov decision process model.
    Van Arendonk KJ; Chow EK; James NT; Orandi BJ; Ellison TA; Smith JM; Colombani PM; Segev AD
    Transplantation; 2015 Feb; 99(2):360-6. PubMed ID: 25594552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncertainty and patient heterogeneity in medical decision models.
    Groot Koerkamp B; Weinstein MC; Stijnen T; Heijenbrok-Kal MH; Hunink MG
    Med Decis Making; 2010; 30(2):194-205. PubMed ID: 20190188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial optimization: Monte Carlo simulation Markov model for planning clinical trials recruitment.
    Abbas I; Rovira J; Casanovas J
    Contemp Clin Trials; 2007 May; 28(3):220-31. PubMed ID: 16979387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal of immunosuppression following pediatric liver transplantation: a Markov analysis.
    Mohammad S; Li Z; Englesbe M; Skaro A; Alonso E
    J Pediatr Gastroenterol Nutr; 2014 Aug; 59(2):182-9. PubMed ID: 24813534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of one and two-stage revision of total hip arthroplasty complicated by infection: a Markov expected-utility decision analysis.
    Wolf CF; Gu NY; Doctor JN; Manner PA; Leopold SS
    J Bone Joint Surg Am; 2011 Apr; 93(7):631-9. PubMed ID: 21471416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A piecewise-homogeneous Markov chain process of lung transplantation.
    Sharples LD; Taylor GI; Faddy M
    J Epidemiol Biostat; 2001; 6(4):349-55. PubMed ID: 12036269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mathematical approach for evaluating Markov models in continuous time without discrete-event simulation.
    van Rosmalen J; Toy M; O'Mahony JF
    Med Decis Making; 2013 Aug; 33(6):767-79. PubMed ID: 23715464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monte Carlo estimation of total variation distance of Markov chains on large spaces, with application to phylogenetics.
    Herbei R; Kubatko L
    Stat Appl Genet Mol Biol; 2013 Mar; 12(1):39-48. PubMed ID: 23459470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation.
    Karnon J
    Health Econ; 2003 Oct; 12(10):837-48. PubMed ID: 14508868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markov Models in health care.
    Sato RC; Zouain DM
    Einstein (Sao Paulo); 2010 Sep; 8(3):376-9. PubMed ID: 26760158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probabilistic analysis of decision trees using symbolic algebra.
    Willard KE; Critchfield GC
    Med Decis Making; 1986; 6(2):93-100. PubMed ID: 3702626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.